# Werfen to acquire Immucor for approximately $2 billion

Werfen announced it has agreed to acquire Immucor, Inc. from TPG for approximately US$2 billion. Immucor is a privately held diagnostics company headquartered in Norcross, Georgia. The transaction is expected to close during the first half of 2023.

- Type: Acquisition
- Announced: 2022-11-03
- Where: Norcross, Georgia, United States
- Value: $2.00B
- Status: announced
- Products: transfusion and transplant in vitro diagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [TPG](https://endata.com/companies/10791.md) (investor)
- [Werfen](https://endata.com/companies/21583.md) (acquirer)
- [Immucor](https://endata.com/companies/66403.md) (target)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/werfen-to-acquire-immucor-inc-expanding-its-presence-in-specialized-diagnostics-882650704.html), 2022-11-03: "This acquisition will allow Werfen to expand its portfolio of Specialized Diagnostics solutions for hospitals and clinical laboratories."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.